Contact Us | 1-800-343-7475
Our Immune Cell Therapy Symposium focuses on increasing the speed, sensitivity, and reproducibility of cell therapy manufacturing. Industry leaders will discuss their use of the Ella™ automated ELISA platform for lentivirus titer analysis as well as the functional characterization of engineered B cells and T cells that target multiple tumor-associated antigens.
Speakers & Panel Guests |
|||||
Andrew Greenwald Scientist - Genezen Laboratories Technology Evaluation: Quicker way of Lentiviral Vector Physical Titer Determination |
Juan F. Vera President & CEO - Marker Therapeutics MultiTAA - Specific T-Cells: A Novel Treatment for Cancer |
Mitchell Ambrosino Senior Associate Scientist - Be Biopharma Panel Guest |
|
|||||
Nathan Allen Director, CGT Product Marketing Mgmt. - Bio-Techne Panel Host & Moderator |
David Hermanson Director, CGT Applications - B-MoGen / Bio-Techne Panel Guest |